On May 30, 2018 Mirati Therapeutics, Inc. (NASDAQ: MRTX),reported a clinical stage targeted oncology company, will present at the Jefferies Annual Global Healthcare Conference in New York on Friday, June 8th at 8:30 a.m. ET/ 5:30 a.m. PT (Press release, Mirati, MAY 30, 2018, View Source [SID1234526965]). Charles M. Baum, M.D., Ph.D., President and Chief Executive Officer will present a corporate overview at the conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will be webcast and made available through the "Investors" section of www.mirati.com, and replays will be made available for 90 days following the events.